NCT06118437 Establishment and Validation of a Clinical Predictive Model for Gastrointestinal Cancer Screening Based on Patient-related Risk Factors
| NCT ID | NCT06118437 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Air Force Military Medical University, China |
| Condition | Malignant Tumor of Digestive Tract |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,550 participants |
| Start Date | 2023-07-15 |
| Primary Completion | 2025-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,550 participants in total. It began in 2023-07-15 with a primary completion date of 2025-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Gastrointestinal tumors (esophageal cancer, gastric cancer, colorectal cancer) seriously threaten human health, with a high incidence rate and cancer related hope mortality. Digestive endoscopy is the main method for screening gastrointestinal tumors. Early screening of gastrointestinal tumors can improve the detection of early cancer and improve prognosis. The five-year survival rate of early stage tumors after comprehensive treatment can reach 90%, while the five-year survival rate of late stage tumors is less than 30%. Therefore, the screening of gastrointestinal tumors is very important. Studies have shown that there are similarities in risk factors for gastrointestinal tumors, such as age, gender, family history, smoking, alcohol consumption, etc. Currently, established digestive malignancies are targeted at a single malignant tumor. At present, there is a lack of understanding of the overall risk factors associated with gastrointestinal tumors and the establishment of relevant risk prediction models. Therefore, we conducted a prospective, multicenter cross-sectional study to explore the independent risk factors of combined gastrointestinal tumors and establish a risk prediction model for combined screening of gastrointestinal tumors.
Eligibility Criteria
Inclusion Criteria: * Individuals aged 18-80; * Undergoing both gastroscopy and colonoscopy simultaneously. Exclusion Criteria: * History of esophageal, gastric, or colorectal cancer; * Suspicions of gastrointestinal obstruction or perforation; * History of gastrointestinal tract surgery; * Not suitable for endoscopic examination due to serious diseases or unstable hemodynamics; * Unavailable relevant information; * Pregnancy or lactation period; * Unavailable informed consent form.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06118437 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Malignant Tumor of Digestive Tract. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06118437 currently recruiting?
Yes, NCT06118437 is actively recruiting participants. Contact the research team at yanglinpan@hotmail.com for enrollment information.
Where is the NCT06118437 trial being conducted?
This trial is being conducted at Xi'an, China.
Who is sponsoring the NCT06118437 clinical trial?
NCT06118437 is sponsored by Air Force Military Medical University, China. The trial plans to enroll 1,550 participants.